La dissolution de l'#Icans (Institut de cancérologie Strasbourg) pourrait être prononcée dans les prochaines semaines. S.Henni, DG des HUS (=CHRU de Strasbourg) a informé de son retrait de ce groupement de coopération sanitaire fondé avec le Centre Paul Strauss (CPS) #cancer
@PBlanchardMD @VarianMedSys 4 years later this conversation : we are happy to show a new physician workspace in Aria to collect multicentric real life standardized data. My teammate Dr Clavier will be at Varian's Internation Oncology Summit and at @VarianMedSys booth in #estro2022 for a life demo
Stereotactic body radiotherapy a new SOC for painful spinal metastases? Randomized SBRT 24Gy/2 vs conventional #radiotherapy 20Gy/5:
⬆️complete pain response.
↔️ similar toxicity
Trend towards superior local control
Congrats @SahgalArjun & Team
#ASTRO20
2016 : we started use #mosaiq for #datafarming in #radonc for daily care.
2020 : working on #ontology and data dictionary of our multicentric tool with @Elekta support. Stay tuned for details at ESTRO2020 poster session.
Another trial showing superiority of cisplatin over cetuximab as radiosensitizer for head neck cancer (mostly #HPV p16 oropharynx).
@ 3 yrs, OS 88% vs 78% ( HR 1.63; p=.086), and locoreg failures 23% vs 9% (p=.0036).
Congrats to ARTSCAN III team: https://t.co/VQGEECJRNd
Another MAJOR PROOF of the effectiveness of #HPV#Vaccination@NEJM
https://t.co/4AMJ5UjdHz
"Compared to unvaccinated women, adjusted incidence rate ratio of 0.12 (0.00-0.34) & 0.47 (0.27-0.75) in women vaccinated before 17y & 17-30y."
Now waiting for data on oropharynx cancer
Thanks to the #DAHANCA for making available their H&N cancer #radiotherapy guidelines.
Provides guidance for
☑️ definitive RT
☑️ postop RT
☑️ dose constraints
☑️ considerations for #protontherapy
find them here: https://t.co/RC5Gal6wrB
RSS announces MRI-Linac Consortium to Use RSSearch Patient Registry to Collect and Track MRI-Guided Radiotherapy Treatment Delivery and Outcomes https://t.co/AQAMQRKVaT via @PRWeb
Our paper of phase 2 trial GORTEC 2015-2 Debio1143-201 finally online, potential practice changing trial in locally advanced head and neck cancer @YPointreau
https://t.co/ZdniVvhXhb
More and more interest for our work in real life #radonc data. Poster highlight at #estro2020, #astro2020 and oral communication at @congresSFRO 2020. Thanks to the user community and @Elekta